FFIV (ticker: FFIV) holder files Rule 144 notice to sell 199 shares

Rhea-AI Filing Summary

A holder of FFIV common stock has filed a notice to sell 199 shares on the NASDAQ, with an approximate sale date of 02/03/2026. The proposed sale will be executed through Morgan Stanley Smith Barney LLC Executive Financial Services and has an aggregate market value of 55992.63.

The 199 common shares were acquired from the issuer as restricted stock on 02/01/2026. Over the prior three months, an entity named LYRA sold 1,062 FFIV common shares for gross proceeds of 262282.14, providing context for recent selling activity related to this issuer.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	199	55992.63	58089614	02/03/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/01/2026	Restricted Stock	Issuer			199	02/01/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
LYRA SCHRAMM 801 5TH AVENUE Seattle WA 98104	Common	11/04/2025	1062	262282.14

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does this Form 144 filing indicate for FFIV shareholders?

The filing indicates a holder of FFIV common stock intends to sell 199 shares under Rule 144. These shares were recently acquired as restricted stock, and the notice formally discloses the planned sale and related details, including broker, market, and timing information.

How many FFIV shares are planned for sale in this Form 144?

The notice covers a proposed sale of 199 FFIV common shares. These shares are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ, with an approximate sale date of 02/03/2026 and an aggregate market value listed as 55992.63.

How were the FFIV shares in this Form 144 acquired?

The 199 FFIV common shares were acquired from the issuer as restricted stock. The acquisition date recorded is 02/01/2026, with the same date shown for payment and the nature of payment described as not applicable, indicating a non-cash or equity-based grant structure.

What recent FFIV share sales are disclosed for the past three months?

The filing shows that LYRA, based in Seattle, sold 1,062 FFIV common shares on 11/04/2025. These sales generated gross proceeds of 262282.14, providing a record of recent disposition activity of FFIV securities linked to the person for whose account sales are aggregated.

Which broker and market are involved in the planned FFIV share sale?

The planned sale of 199 FFIV common shares will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services. The shares are listed to be sold on the NASDAQ exchange, giving investors clarity on the trading venue and intermediary for this Rule 144 transaction.

What is Rule 144’s role in this FFIV stock transaction?

Rule 144 governs resales of restricted and certain control securities, and this notice relates to a planned FFIV sale under that rule. The form collects information on the seller, acquisition method, share amounts, and recent sales that must be aggregated for regulatory compliance.